Welcome back. President Trump signing a new executive order focused on the pharma supply chain, aiming to fill the country's strategic active pharmaceutical ingredients reserve to bolster domestic manufacturing and calling for the creation of a new list of drugs that are quote critical to the health and security interests of America. For more on the order, we're joined now by Peter Navaro, White House senior counselor on trade and manufacturing.It's it's great to have you, Peter. So, how exactly does this w ...